维普中文期刊产品整合服务
79篇 您的检索式:作者名="SUNYe"
    题名 作者 年代 出处 被引量
1对于提高奥氏体不锈钢离子氮化表面腐蚀性能的措施显示文摘离子氮化已经非常成功地应用在奥氏体不锈钢的表面强化方面,以提高其耐磨性与摩擦学性能。然而由于氮化铬在氮化层中沉淀析出,在许多受环境严重腐蚀的应用场合,使传统的离子氮化耐腐蚀性能恶化,这是无法接受的。最近几年,作者企图提高奥氏体不锈钢离子氮化的耐腐蚀性能,以获得既耐磨又耐腐蚀的表面。为此,进行了两方面的探索即传统的高温氮化后紧接着表面钝化处理,以及低温氮化处理。前者产生一种较厚且耐磨的亚表面氮化层和耐腐蚀的表面钝化膜。而低温氮化处理可产生一层薄且硬的无沉淀析出的非常耐腐蚀的氮化物层。本文讲述了针对奥氏体不锈钢进行各种氮化处理的最新试验结果,并讨论了其显微组织、动力学、耐磨性和耐腐蚀性能。T.BELL LiXY SunY 刘家浚 张秋英 1998中国表面工程1998,11,4:13
2Soluble Expression,Purification and Characterization of Single-chain Fv Catalytic Antibody(sFv-2F3)显示文摘To find optimal conditions for expressing the soluble form of sFv-2F3 and to study the purification and property of its derivative Se-sFv-2F3,the preferred expression conditions were investigated by means of orthogonal design. These culture conditions included incubation temperature,inducer concentration, induction time and cell concentration. The evaluation of expression was accomplished by the analysis of whole cell lysates and the yield of soluble sFv-2F3 was calculated according to the analysis of Profinder(FTI-500,Pharmacia). The purification procedure was carried out via a two-step purification procedure consisting of ion-exchange chromatography,followed by immobilized metal affinity chromatography(IMAC). The antioxidant efficacy of Se-sFv-2F3 was demonstrated by the determination of the content of the main product of lipid peroxidation,MDA,the viability of cells and the activity of LDH. We obtained the preferred culture conditions to grow the engineered bacteria and the procedure for preparing soluble sFv-2F3 and confirmed the antioxidant efficacy of Se-sFv-2F3.SUNYe LIWei-jia MAJi-sheng MUYing DUXiu-bo YANGang-lin LUOGui-min 2004Chemical Research in Chinese Universities2004,20,3:2
3Hydrolysis of lignocellulosic materials for ethanol production:a review显示文摘SunY Cheng JY 0,,01:1
4HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study 显示文摘SunY Liu X Guo L 2014Int J Cardiol2014,172,2:1
5Tissue angiotensin 11 and myocardial infarction显示文摘SunY Weber KT 1996EXS1996,76,:1
6The biocontrol of Pseudomonas fluorescens (in Chinese) [J]显示文摘YangY SunY LiZ 2012西北大学学报2012,10,1:1
7Invitroactivityofminocyclinealoneand in combination with cefoperazone - sulbactam againstcarbapenem-resistantAcinetobacterbaumannii显示文摘PEIG MAOY SUNY 2012MicrobDrugResist2012,18,6:1
8Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism:a new surgical approach显示文摘SunY CaiH BaiJ etal 2009World J Surg2009,33,:1
9EGFR-mediatedexpressionofaquaporin-3isinvolvedinhumanskinfibroblastmigrat-ion显示文摘CaoC SunY HealeyS etal 2006Biochem2006,400,2:1
10Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process显示文摘Bos O J Sunye DG Nieuweboer CE 1998Biologicals1998,26,4:1
11Rab8A and Rabl3are activated by insulin and regulate GLUT4 transloca-tion in muscle cells 显示文摘SUNY BILAN P J LIU Z 2010Proceedings of the NationalAcademy of Sciences of the United States of Ameri-ca2010,107,19:1
12VEGF-induced neureproteetion, neurogenesis, and angiogenesis after focal cerebral ischemia 显示文摘SunY Jin K Xie L 2003Clin Invest2003,111,12:1
13Result of phase II1 trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small cell lung cancer显示文摘SunY Cheng Y Hao X 2013J Clin Oncol2013,2013,:1
14Interaction between Eu (III) and graphene oxide nanosheets investigated by batch and extended X - ray absorption fine structure spectroscopy and by modeling techniques 显示文摘SunY Wang Q Chen C 2012Environ- mental science & technology2012,46,11:1
15Apogossypolone,anonpeptidicsmallmoleculeinhibitortargetingBcl-2familyproteins,effec-tivelyinhibitsgrowthofdiffuselargecelllymphomacellsinvitroandinvivo显示文摘SunY WuJ AboukameelA etal 2008CancerBiolTher2008,7,9:1
16Neuronal nitrc oxide synthase and iscllemia-induced neurogenesis显示文摘sunY Jin K Childs JT 2005J Gereb Blood Flow Metab2005,25,4:1
17Imbalancebetweensubpopula-tionsofregulatoryTcellsinCOPD显示文摘HouJ SunY HaoY etal 2013Thorax2013,12,7:1
18Evaluation of the bac-terial diversity among and within individual venous leg ulcers usingbacterial tag-encoded FLX and titanium amplicon pyrosequencingand metagenomic approaches显示文摘Wolcott RD Gontcharova V SunY 2009BMC Microbiol2009,9,:1
19A self-learning segmentation framework-the Taguchi approach显示文摘Chen D SunY 2000Comp Med Imag Graph2000,24,5:1
20Effect of 2-Selenium Bridged β-Cyclodextrin,Glutathione Peroxidase Mimic on Stroke of Stroke-prone Spontaneously Hypertensive Rats显示文摘To investigate the treatment effect of 2-selenium bridged β -cyclodextrin(2-SeCD),a GPX mimic,on the stroke of stroke-prone spontaneously hypertensive rats(SHRSP),fifty-two SHRSP of 8-week old were randomly divided into four groups A,B,C and control group D. The rats of groups A,B,C and D were given 1.0%-1.5% NaCl mass fraction as drinking fluid. After onset of stroke,groups A,B and C were given \{orally\} 16.05,160.5 and 1605 mg·kg -1 ·day -1 of 2-SeCD,respectively,and group D was given water for \{2 weeks.\} The clinical score of stroke,systolic blood pressure(SBP),survival time of rats were recorded and the histopathologic examinations of their brain and carotid artery were made after decapitation. The clinical scores of stroke after treatment with 160.5 mg·kg -1 ·day -1 (Group B) and 1605 mg·kg -1 ·day -1 (Group C) of 2-SeCD are 2.55±0.98 and 1.98±0.79,respectively,those are obviously lower than that of group D(3.41±0.83,p<0.01). The survival days in group B(10.0±8.6) and group C(14.4±7.9) are longer than that for group D(4.7±2.9,p<0.01). The electron microscope study showed that the endothelium of carotid artery was near to normal in group B and group C,while it was seriously injured in control group D and mildly injured in group A. 2-SeCD may effectively be used to treat the stroke for SHRSP.JIAZhi-dan SUNYe MUYing MAJi-sheng YANGang-lin LUOGui-min 2004Chemical Research in Chinese Universities2004,20,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费